KCL ethics approval #: HR-22/23-36258
Principal Investigator: Tayler Holborn, MRes, BSc
Sponsor: King’s College London, Institute of Psychology, Psychiatry and Neuroscience
Self-rated effectiveness of novel psychoactive substances (NPS) in self-medicating mood and anxiety disorders
The purpose of this study is to assess self-medication with NPS. There is evidence to suggest that individuals may be self-medicating with NPS, however this is scarcely represented in the academic literature. We aim to examine the self-rated effectiveness (SRE) of novel psychoactive substances (NPS) for mood and anxiety disorders compared to conventionally prescribed treatments. As a proponent of evidence-based drug policy, we hope that understanding how NPS are being used can help to positively influence drug policy.
To find out more about the study, visit the following link: https://qualtrics.kcl.ac.uk/jfe/form/SV_40mqmjI0bKQmtlI
What will happen if I take part?
If you agree to take part you will complete a survey anonymously. The survey will take you approximately 15 minutes to complete. The survey will ask you questions about your gender, age, ethnicity, country of residence, medication you may be using and its effectiveness, NPS you may be using and its effectiveness and your perceptions of professional healthcare. The survey will also ask about the mood/anxiety disorder you are suffering from and your mental health experiences.
Who is eligible to participate?
You are being invited to participate in this study because we are interested to hear from the general public. If you are 18-years old, or older, understand English, and have used/are using a NPS to self-medicate a mood or anxiety disorder, then you are eligible to participate in this study. To participate you do not require a formal mood or anxiety disorder diagnosis.
If you have any questions, please contact Tayler Holborn (tayler.j.holborn@kcl.ac.uk).
